page 1 | page 2  

Issue 1  /  April 21, 2004
Editors: Margaret "Peggy" McMahon, J.D., Director NITDC Denver; and Arlen Meyers, M.D., Executive Director, CAB

DID YOU KNOW?
The only Center for Disease Control (CDC) full office outside of Atlanta headquarters is in Colorado? CDC opened the Colorado office in the 1960's largely because of Colorado State University's history of infectious disease research. CDC Colorado deals with bacterial and viral vector borne disease.
CAB Leads Colorado Academic Bioengineering Initiative/ Fellowship Announcement
The Colorado Alliance for Bioengineering (CAB), is a consortium of Colorado research universities committed to producing a high quality workforce and enhancing bioengineering research and development in the state of Colorado.

Biomedical engineering is the scientific discipline that applies engineering sciences solutions to life science questions. The promise of biomedical engineering research and its practical applications are to improve and extend the lives of persons throughout the world. CAB has its origins in meeting the need to encourage additional research and education in bioengineering combined with facilitating the complex task of developing devices, information programs and systems usable by health related organizations. more »

 

Fusion Antibodies: Success in Denver: Major Partnerships Clinched
Biotechnology is a dynamic and growing sector, Fusion Antibodies, a Belfast-based company is right at the forefront in its field. Fusion may be a small and relatively young company, but it boasts a client list which includes some of the worldıs leading research institutions such as the National Cancer Institute, Center for Disease Control (CDC), National Institutes of Heath in the USA, as well as leading UK and Irish Universities. The Company is working in collaboration with leading biotech companies in US and Europe.
more »

 

Colorado TB researcher David Cohn, MD: looking around the world for answers
One third of the people in the world are infected with tuberculosis (TB). Eight million new active cases occur each year and 2 million die each year, most of them unnecessarily, according to University of Colorado TB researcher David Cohn, MD. "It's an enormous international problem, and now amplified further by the HIV/AIDS pandemic", says Cohn, Associate Director of the Denver Department of Public Health and Professor of Medicine in the Division of Infectious Diseases at the University of Colorado Health Sciences Center. more »


Questions, comments, inquiries? Contact Peggy McMahon, J.D., Director, NITDC Denver
Copyright © 2004 NITDC Denver. All rights reserved.

[ page 1 | page 2 | top of page ]